Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 16

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 16
---
 our executive officers,
directors, nominees for election as a director, beneficial owners of more than 5% of any class of our common stock and any members of
the immediate family or affiliate of any of the foregoing persons are not permitted to enter into a related person transaction with us
without the approval or ratification of the Audit Committee. Any request for us to enter into a transaction with an executive officer,
director, nominee for election as a director, beneficial owner of more than 5% of any class of our common stock, or any member of the
immediate family or affiliate of any of the foregoing persons, in which the amount involved exceeds $120,000 and such person would have
a direct or indirect interest, must be presented to the Audit Committee for review, consideration and approval. In approving or rejecting
any such proposal, the Audit Committee is to consider the material facts of the transaction, including whether the transaction is on terms
no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent
of the related person’s interest in the transaction.

| 8 |

<div align='center'>PROPOSAL No. 1 –APPROVAL OF A REVERSE STOCK SPLIT OF OUR COMMON STOCK AT A RATIO IN THE RANGE OF 1-FOR-5 TO 1-FOR-12, WITH SUCH RATIO TO BE DETERMINED IN THE DISCRETION OF OUR BOARD OF DIRECTORS AND WITH SUCH REVERSE STOCK SPLIT TO BE EFFECTED AT SUCH TIME AND DATE AS DETERMINED BY OUR BOARD OF DIRECTORS IN ITS SOLE DISCRETION (BUT IN NO EVENT LATER THAN May 13, 2026).</div>

Background

Our Board of Directors has unanimously approved a
reverse stock split of all issued and outstanding shares of our common stock, at a ratio ranging from 1-for-5 to 1-for-12, inclusive,
or the Reverse Stock Split, pursuant to Nevada Revised Statutes, or NRS, 78.2055.

Effecting the Reverse Stock Split would reduce the
number of outstanding shares of our common stock. The determination to effect a Reverse Stock Split, including the ratio and the effective
date and time of any such Reverse Stock Split, will be determined by our Board of Directors within a reasonable time following the Special
Meeting. Our Board of Directors has recommended that the proposed Reverse Stock Split be presented to, and approved by, our stockholders.

Pursuant to